Clearance Summary
S40 CREATINE KINASE (CK) received FDA 510(k) clearance under submission number K082226, sponsored by Alfa Wassermann Diagnostic Technologies, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2008-09-18.
- Submission: K082226
- Applicant / Sponsor: Alfa Wassermann Diagnostic Technologies, Inc.
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1215
- Decision date: 2008-09-18
Classification & Regulation
This clearance is catalogued under FDA product code JHS and 21 CFR 862.1215, within the Clinical Chemistry review panel as a Class II device.